SRHU represented at 45th Annual Meeting of European Thyroid Association, at Milan ITALY

Published on: October 7, 2023

Swami Rama Himalayan University represented at 45th Annual Meeting of European Thyroid Association, at Milan ITALY

Dr Nikku Yadav, Assistant Professor, Department of Community Medicine, represented SRHU at the 45th Annual Meeting of European Thyroid Association (ETA), at Milan, ITALY

The University of Milan hosted the 45th Annual Meeting of European Thyroid Association (ETA) from September 9th to 12th September, 2023.

The meeting initiated by local organizing committee Milan, was chaired by Laura Fugazzola and Luca Persani. They informed that the ETA Annual Meeting in Milan was being held for the second time after 1999.

Thyroidologists and guests from world over congregated in good numbers.

‘Oral Session 1 Highlights in Thyroidology: in Memory of Jacques Dumont’ was conducted at the onset.

The poster presentation on Cancer, Graves’ Disease, Miscellaneous Nodules-surgery, Thyroid hormone diagnostics, Thyroid Cancer Clinical 1, Thyroid Cancer Diagnosis 1, Translational 1, Thyroid Cancer, Basic Thyroid Gland, Iodine & Autoimmunity Basic was conducted and evaluated. Satellite sessions were also conducted by industry experts, including on Robotic surgery of thyroid disease.

Dr Nikku Yadav’s poster entitled “Reference Range of Maternal Thyroid Hormones from Rural Himalayan Foot Hills (Tehri Cluster): A Cross Sectional Study”, was submitted under Thyroid Gland, Iodine & Autoimmunity Basic category. The poster presentation was followed by a QA round within time limits.

The poster appraised by Dr Marina A Michalaki, Division of Endocrinology, Department of Internal Medicine, University of Patras School of Health Sciences, Greece, was appreciated by members as representing significant work being conducted in the mountains.

On the second day Oral Session 2: Thyroid hormone action in the brain, Oral Session 3: Signalling in Thyroid cancer, Oral Session 4: Young Investigators / Clinical and Translational, Oral Session 5: Young Investigators / Basic were conducted.

The poster session 2 on Miscellaneous Nodules, Surgery Case Reports 1, Hyperthyroidism, Thyroid Cancer clinical 2, Thyroid Cancer Diagnosis 2 Treatment 1, Thyroid Hormone Transport & Metabolism Basic, Thyroid hormone receptors basic were conducted.

A Special session “How to design a clinical trial for advanced thyroid cancer” by Lori Wirth (USA) was also conducted.

On the third day of meeting oral sessions on the following themes were conducted: Oral Session 6: Pregnancy, Oral Session 7: Thyroid hormone receptors, Oral Session 8: Hypothyrodism / Nodules, Oral Session 9: Thyroid Eye Disease, Oral Session 10: Novel diagnostics in Thyroid cancer. Furthermore, Hypothyroidism, Nodules 2, Pregnancy, Thyroid Eye Disease, Case Reports 2, Thyroid hormone diagnostics 2, Thyroid Cancer clinical 3, Translational 2, Treatment 2, Thyroid Physiology in Periphery & Development Basic.

Meet the expert session included Transcriptomics analysis in thyroid hormone action by Soledad Barez-Lopez (Spain).

On the last day, Oral Session 11: Autoimmunity / Hyperthyroidism, Oral Session 12: Emerging Insights into Thyroid Cancer Genetics, Oral Session 13: Pathophysiological actions of thyroid hormones were conducted. Meet the expert session on Human brain organoids: new models of thyroid hormone action during neuronal development by Robert Opitz (Germany) was amongst the highlights.

Last of all the closing ceremony by Laura Fugazzola (Italy) and Kris Poppe (Belgium) was conducted. “A great discussion with all the renowned scientists was intellectually really stimulating, throwing up ideas for further research in the field of Endocrinology,” states Dr Yadav.

it5.jpeg
it2.jpeg
it4.jpeg
it1.jpeg
it6.jpeg
it3.jpeg
   Admissions Form         

Admission Open For 2025

×
International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.